EosDx Inc.
John Pavlidis is an accomplished executive in the medical device and healthcare IT sectors, currently serving as the Chief Executive Officer and Director on the Board of Directors at EosDx Inc., which specializes in pre-symptomatic non-invasive cancer detection. With extensive experience as a consultant and board director for various start-ups, John Pavlidis has held leadership positions in notable companies such as Vytronus, Inc. and Estech, Inc., and has contributed to the success of organizations like U-systems and Clario Medical Imaging. John Pavlidis holds a Master of Science in Engineering Sciences from Dartmouth College and a Bachelor of Science in Biomedical Engineering from Rensselaer Polytechnic Institute.
This person is not in any teams
This person is not in any offices
EosDx Inc.
EosDx Inc. is committed to bringing live changing innovation to breast cancer diagnostics with our fundamentally new approach. Our efforts are focused on significantly improving diagnostic procedures, which follow after a suspicious mammography image is identified. Ultimately our goal is to introduce completely non-invasive biopsy procedure, eliminating the need for tissue extraction. EosDx method uses X-ray radiation to obtain digital quantified molecular structure data of the tissue which has been shown to be highly sensitive to its health status. Research has shown that molecular structure changes immediately in response to its pathological status and this change propagates to a significant distance from the origination site, making it possible to detect pathology very early and with the highest degree of accuracy.